Category: Prevention
-
-
Save the date: Abidi Hypertension and Hyperlipidemia Academy
April 19, 2021Keeping up-to-date on HTN and DLP treatment
-
Self-measured blood pressure monitoring at home
April 17, 2021What to teach the patients about recording their blood pressure themselves
-
Impact: No-LVT trial
April 13, 2021Comparative study of oral anticoagulation in left ventricular thrombi
-
DiaBeat: The Beating Heart of Diabetes (4th session)
April 12, 20214th Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (3rd session)
April 12, 20213rd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (2nd session)
April 11, 20212nd Diabetes Masterclass for Cardiologists
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
April 7, 2021Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline
April 6, 2021Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
-
-
-
PCSK9 inhibitors place in patients with cardiometabolic diseases
March 16, 2021PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist
-
CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI
March 11, 2021Quick Review of ACC 2020 Expert Consensus Pathway of Antithrombotic Management
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
-
Cardiometabolic Grand Round (3)
February 27, 2021A brief talk on DM medication challenges in patients with CVD
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Save the date; DiaBeat: The Beating Heart of Diabetes
February 23, 20214th Diabetes Masterclass for Cardiologists
-
Guideline Directed Medical Therapy in Patients with HF
February 17, 2021Quick review on place of MRAs in patients with HFrEF
-
Guideline Directed Medical Therapy in Patients with HF
February 7, 2021Quick review on place of Beta-Blockers in patients with HFrEF
-
CardioPoint (10): The growing burden of cardiovascular diseases
February 2, 2021Emphasizing the importance of CVD prevention and management
-
Guideline Directed Medical Therapy in Patients with HF
February 1, 2021Updates on ACEI/ARB place in patients with HFrEF (2021 Guideline)
-
Save the date; DiaBeat: The Beating Heart of Diabetes
January 28, 20213rd Diabetes Masterclass for Cardiologists
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
10th Case: Drug Drug Interactions
January 21, 2021DOACs important interactions in clinical practice
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
-
-
Seventh Case: Thrombocytopenia
January 21, 2021Any Concerns for OACs Use in Patients with Thrombocytopenia
-
Sixth Case: Hepatic Impairment
January 21, 2021OAC of choice in patients with hepatic impairment, any difference between DOACs?
-
-
Forth Case: Extreme Body Weights
January 21, 2021OAC choice in patients with obesity or low body weights, any role for DOACs?
-
Third Case: AF & Artificial Heart Valves
January 21, 2021OAC of choice in patients with artificial heart valves
-
Second Case: Cancer associated VTE
January 21, 2021Anticoagulation of choice in patients with cancer, the importance of DDI
-
First Case: Elective PCI and AF
January 21, 2021Antithrombotic regimen of choice in patients with AF undergoing elective PCI
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
SGLT2 inhibitors in the treatment of HF: the future is bright?
January 12, 2021Cardiologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: A snapshot into their evolution
January 12, 2021Endocrinologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Residents’ Island: Abidi CVD Prevention Academy
January 12, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: Residents’ Island; Abidi CVD Prevention Academy
January 1, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: SGLT2 inhibition: Making waves in the heart failure landscape
December 31, 2020Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Save the date: Cardiometabolic Grand Round (2)
December 27, 2020A brief talk on DM medication challenges in patients with CVD
-
Impact: EMPA-RESPONSE-AHF
December 7, 2020Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)
-
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
December 7, 2020Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences
-
Cardiometabolic Grand Round (2)
December 7, 2020A brief talk on DM medication challenges in patients with CVD
-
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
December 3, 2020Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs
-
A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)
December 2, 2020A quick review on the findings of TIPS-3 trial from AHA congress 2020
-
The role of Omega 3 and Vitamin D in the Primary Prevention of AF (VITAL-RHYTHM Trial)
December 2, 2020Dietary Supplements and AF
-
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)
December 2, 2020The Important findings of SCORED trial from AHA 2020 congress in brief
-
High Dose Vs Standard Dose Influenza Vaccine in Patients with a High-Risk for Cardiovascular Disease (INVESTED)
December 2, 2020A quick review on the findings of INVESTED trial from AHA congress 2020
-
Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in HF (GALACTIC-HF Trial)
December 2, 2020A quick review on the findings of GALACTIC-HF trial from AHA congress 2020
-
Rilonacept (IL-1α and β inhibitor) in the treatment of recurrent pericarditis
November 30, 2020a pivotal symptomatology and outcomes study (RHAPSODY Trial)
-
Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor+ASA for Prevention of Stroke and Death (THALES Trial)
November 30, 2020The effects of Ticarelor+ASA in Acute Stroke
-
-
Rivaroxaban in Patients with AF and a Bioprosthetic Mitral Valve
November 26, 2020The findings of RIVER trial
-
Cryoablation or Drug Therapy for the Initial Treatment of AF (EARLY-AF)
November 26, 2020Treatment strategies of AF
-
Enhanced Monitoring for AF Following Cardiac Surgery (SEARCH-AF)
November 26, 2020Detection of AF after cardiac surgery
-
New FDA approved indication for Ticagrelor
November 6, 2020Ticagrelor approved for recurrent stroke prevention
-
Save the Date: Antithrombotic Therapy to Prevent Cardiovascular Events in Type 2 Diabetes
November 4, 2020Comprehensive talk on DAPT vs Low dose Rivaroxaban in patients with T2DM and CVD
-
Treatment goals for LDL cholesterol across categories of total CV risk
November 4, 2020Overview of 2019 ESC/EAS Guidelines for the management of dyslipidemia
-
Finerenone Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD Trial)
November 3, 2020Finerenone protecting kidneys
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
November 3, 2020Part Two: Prevention of thromboembolic events Patients with AF and an ACS, PCI or CCS
-
Save the date: Cardiometabolic Grand Round
November 1, 2020A brief talk on DM management in patients with CVD
-
-
Monitor eGFR in Patients Treated with Metformin
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Glycemic Management for patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Save the date: ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 31, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Save the date: Comprehensive risk reduction in DM
October 29, 2020Collaborative management of DM: Endocrinologist, Nephrologist and Cardiologist team work
-
How to Implement the Newest Diabetes Therapies in HF Treatment
October 29, 2020New insight from EMPEROR Reduced Trial
-
Save the Date: What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
Save the date: VTE Prophylaxis in Patients with COVID-19
October 20, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
VTE Prophylaxis in Patients with COVID-19
October 19, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
At a glance; Place of FDC in CV outcomes
October 7, 2020Single-Pill Combination Therapy and CV Outcomes in HTN
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
October 3, 2020Updated changes in AF ESC 2020 compared to previous Guidelines (Part one)
-
ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 2, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Diabetes and Cardiovascular Diseases
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Smoking and the Heart the Struggle Continues
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
The weight of the world: The global challenge of obesity
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
-
Ground-breaking research from ESC Congress 2020 (23)
September 16, 2020Part Twenty-three: Trial Review, ELDERCARE-AF
-
Ground-breaking research from ESC Congress 2020 (22)
September 16, 2020Part Twenty-Two: Trial Review, ATPCI
-
Ground-breaking research from ESC Congress 2020 (21)
September 16, 2020Part Twenty-One: Trial Review, BPLTTC (CANCER)
-
Ground-breaking research from ESC Congress 2020 (20)
September 16, 2020Part Twenty: Trial Review, POPULAR TAVI
-
Ground-breaking research from ESC Congress 2020 (18)
September 16, 2020Part Eighteen: Trial Review, HOME-PE
-
Ground-breaking research from ESC Congress 2020 (17)
September 16, 2020Part Seventeen: Trial Review, REALITY
-
Ground-breaking research from ESC Congress 2020 (16)
September 16, 2020Part Sixteen: Trial Review, BPLTTC
-
Ground-breaking research from ESC Congress 2020 (15)
September 16, 2020Part Fifteen: Trial Review, PARALLAX
-
Ground-breaking research from ESC Congress 2020 (14)
September 16, 2020Part Fourteen: Trial Review, POPULAR CABG
-
Ground-breaking research from ESC Congress 2020 (12)
September 16, 2020Part Twelve: Trial Review, EVAPORATE
-
Ground-breaking research from ESC Congress 2020 (11)
September 16, 2020Part Eleven: Trial Review, DAPA-CKD
-
Ground-breaking research from ESC Congress 2020 (10)
September 16, 2020Part Ten: Trial Review, DECLARE-TIMI
-
Ground-breaking research from ESC Congress 2020 (9)
September 16, 2020Part Nine: Trial Review, RATE-AF
-
Ground-breaking research from ESC Congress 2020 (8)
September 16, 2020Part Eight: Trial Review, COPS
-
Ground-breaking research from ESC Congress 2020 (7)
September 16, 2020Part Seven: Trial Review, COLCOT
-
Ground-breaking research from ESC Congress 2020 (6)
September 16, 2020Part Six: Trial Review, LoDoCo2
-
Ground-breaking research from ESC Congress 2020 (5)
September 16, 2020Part Five: Trial Review, EAST-AFNET4
-
Ground-breaking research from ESC Congress 2020 (4)
September 16, 2020Part Four: Trial Review, BRACE-CORONA
-
Ground-breaking research from ESC Congress 2020 (3)
September 16, 2020Part Three: Trial Review; THEMIS, PAD
-
Ground-breaking research from ESC Congress 2020 (2)
September 16, 2020Part Two: Trial Review, EMPEROR-REDUCED
-
Save the date: Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Case Discussion (30)
September 12, 2020Optimal Antithrombotic Regimen Early & Late After Discharge in Patients Presenting With STEMI
-
-
Save the date: Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
-
-
Impact: Mavacamten for the treatment of symptomatic HCM
August 31, 2020The findings of EXPLORER HCM trial
-
Impact: Aspirin with or without Clopidogrel after TAVI
August 31, 2020The findings of POPULAR TAVI trial
-
Impact: cardiovascular and renal outcomes of Empagliflozin in HF
August 31, 2020The findings of EMPEROR-REDUCED trial
-
-
Impact: Intracoronary infusion of bone marrow-derived mononuclear cells in AMI
August 31, 2020The findings of BAMI trial
-
Impact: Time-to-treatment of Colchicine and post-MI cardiovascular outcomes
August 31, 2020The findings of COLCOT trial
-
Save the date: Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Save the date: Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Case Discussion (29)
August 12, 2020Pharmacotherapy approach to ACE/ARB induced AKI in HFrEF patients
-
Pharmacological approach to ACS management in patients on DOAC
August 12, 2020Challenges on fibrinolytic therapy and primary PCI issues in admitted ACS patients on DOACs
-
-
At a glance; FDC role in HTN Pharmacotherapy
August 9, 2020Fixed dose combination therapy in HTN Treatment
-
-
-
-
-
-
Save the date: Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
-
-
-
Dosage Modification of DOACs in Different Clinical Scenarios & in Renal Impairment
July 3, 2020Algorithmic approach to DOACs Dose Adjustment in CKD
-
Save the date: Optimizing Heart Failure Care Throughout the Patient Journey
June 30, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
-
Optimizing Heart Failure Care Throughout the Patient Journey
June 25, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
Low-dose Rivaroxaban in Management of PAD Patients
June 23, 2020Insights from COMPASS & VOYAGER Trials
-
-
Low-dose Rivaroxaban in Management of Post-Revascularized CAD Patients
June 23, 2020Insights from COMPASS-PCI & COMPASS-CABG Trials
-
At a glance; How dual pathway found its way into ESC guidelines?
June 7, 2020Rivaroxaban on board for CCS
-
-
-
-
-
CardioPoint (8): When to consider drug treatment in hypertension?
May 24, 2020A Brief Description on Practical Points in Cardiometabolic Field
-
Save the date: Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
May 13, 2020The role of medications in the pre and post prophylaxis against COVID-19
-
COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 12, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
May 10, 2020The role of medications in the pre and post prophylaxis against COVID-19
-
-
Case Discussion (5)
May 4, 2020Evidenced based discussion on routine cases of cardiology in clinical practice - Antithrombotic Therapy in CCS
-
Save the date: COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 3, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
COVID and Cardiometabolic Challenges
April 10, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
Save the date: COVID and Cardiometabolic Challenges
April 3, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
-
At a glance: ACEI and ARB in COVID-19 Era
March 19, 2020The challenge of to use or not to use ACEI/ARBs in patients with COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Save the date: COVID-19 Sharing Facts, Not the Fear
March 3, 2020Quick review on COVID-19 from an ID Perspective
-
-
-
Predicting the Risk of Post-stroke Atrial Cardiopathy
February 27, 2020An interim analysis from ACARDIA trial
-
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
February 12, 2020Insights from DECLARE-TIMI 58 Trial
-
Intensive LDL lowering beyond current recommendations for MACE prevention
February 12, 2020A meta-analysis of RCTs
-
OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm
February 3, 2020A meta-analysis of RCTs
-
-
Complete vs. Culprit-only Revascularization in Patients with STEMI and Multi-Vessel Coronary Disease
January 21, 2020A meta-analysis of RCTs
-
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
January 18, 2020The renal and cardiovascular protective effects of SGLT2 inhibitors
-
Intensive Blood Pressure lowering and the Concerns about Falling
January 18, 2020The findings of SPRINT trial
-
Case Discussion (2)
January 4, 2020Evidenced based discussion on routine cases of cardiology in clinical practice - Approach to high CAC score
-
-
Cardiology Close-Up (10)
January 2, 2020Antithrombotic Therapy in Patients with Chronic Coronary Syndrome and in Sinus Rhythm
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Three)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Two)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part One)
-
-
-
Case Discussion (1)
December 4, 2019Evidenced based discussion on routine cases of cardiology in clinical practice Appropriate OAC choice in AF
-
-
Inclisiran for patients with ASCVD and elevated LDL
December 2, 2019The findings of ORION-10 trial in ASCVD patients
-
Dapagliflozin in non-DM Patients with HF and Reduced EF
December 2, 2019The findings of DAPA-HF trial in non-diabetics
-
Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL
November 29, 2019The findings of ORION-9 trial about Inclisiran in HeFH
-
The Efficacy and Safety of Low-Dose Colchicine after MI
November 29, 2019The findings of COLCOT trial about colchicine post-MI
-
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
November 29, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome
November 29, 2019The findings of ISCHEMIA trial
-
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis
November 29, 2019The findings of RECOVERY trial
-
Anti-ischemic Medications
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome
November 12, 2019Rivaroxaban versus warfarin in APS
-
Antithrombotic treatment after CABG
November 12, 2019A recent meta-analysis on post-CABG Antithrombotic therapy
-
Triglyceride Lowering and Cardiovascular Risk Reduction
November 4, 2019A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs
-
Guideline Made Easy
November 3, 2019Practical Guide for treatment of high blood cholesterol Part Three
-
-
Bedtime hypertension treatment improves cardiovascular risk reduction
October 29, 2019The findings of Hygia Chronotherapy Trial
-
Peri-operative beta-blockers in non-cardiac surgery
October 24, 2019The findings of Cochrane database systematic review
-
Daily Cardiology Cath-Conference: Case no. 2
October 23, 2019The second case of Daily Cardiology Cath-Conference
-
Cardiology Close-Up (7)
October 7, 2019Pharmacologic Therapy for LDL Cholesterol Treatment Goal and Pharmacologic Therapy for LDL Cholesterol
-
Guideline Made Easy
October 3, 2019Practical Guide for treatment of high blood cholesterol Part Two
-
Ticagrelor with or without Aspirin in High-Risk patients after PCI
September 28, 2019The findings of TWILIGHT Trial
-
CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension
September 20, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
-
AF Patients on NOACs Undergoing Elective PCI or Angiography: When to Hold?
September 3, 2019Pre-procedural management of DOACs
-
Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin
August 24, 2019The findings of COMPASS trial
-
OAC Monotherapy in Patients with Stable CAD and Non-valvular AF
August 20, 2019OACs in Stable CAD and AF
-
-
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI
August 3, 2019P2Y12 loading dose timing in PCI
-
Lisinopril vs Carvedilol for Trastuzumab Cardiotoxicity in Breast Cancer
July 9, 2019Preventing the cardiotoxicity of Trastuzumab
-
-
Ezetimibe for the prevention of heart disease and death
June 14, 2019The role of Ezetimibe in reducing CVD adverse outcomes
-
-
Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half
May 29, 2019The findings of REASTART Trial
-
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA
May 25, 2019DAPT after ischemic stroke or TIA
-
CardioPoint (1):Statins-Who is eligible?-Which dose?
May 19, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
-
-
-
-
Cardiology Close-Up (1)
March 7, 2019Management of Antithrombotic Therapy in AFib Patients Undergoing PCI
-
Case Discussion (26)
September 4, 2017The optimal duration of beta-blocker therapy after myocardial infarction
-
-
Case Discussion (8)
July 12, 2017An ignored challenge in HTN management: Non-dippers An evidence-based discussion
-
